Quarterly Result10 Feb 2026, 10:21 pm
Sampre Nutritions Ltd to Approve Q3 & Nine-Month Financial Results and Appoint New Director on Feb 13, 2026
AI Summary
Sampre Nutritions Ltd has scheduled a Board of Directors meeting on 13th February 2026 to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine-month period ended 31st December 2025. Additionally, the Company will appoint a new non-executive non-independent additional director on the Board.
Key Highlights
- Sampre Nutritions Ltd to approve Q3 and nine-month financial results for the period ending 31st December 2025
- Unaudited standalone and consolidated financial results to be discussed in the meeting
- Appointment of a new non-executive non-independent additional director on the Board of the Company
Price Impact
More from SAMPRE